EKINOPS (EKI.PA) Fundamental Analysis & Valuation

EPA:EKI • FR0011466069

Current stock price

2.66 EUR
+0.31 (+12.95%)
Last:

This EKI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EKI.PA Profitability Analysis

1.1 Basic Checks

  • EKI had negative earnings in the past year.
  • EKI had a positive operating cash flow in the past year.
  • In multiple years EKI reported negative net income over the last 5 years.
  • In the past 5 years EKI always reported a positive cash flow from operatings.
EKI.PA Yearly Net Income VS EBIT VS OCF VS FCFEKI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • The Return On Assets of EKI (-2.90%) is comparable to the rest of the industry.
  • EKI has a Return On Equity of -5.32%. This is comparable to the rest of the industry: EKI outperforms 43.75% of its industry peers.
Industry RankSector Rank
ROA -2.9%
ROE -5.32%
ROIC N/A
ROA(3y)-1.59%
ROA(5y)0.97%
ROE(3y)-2.83%
ROE(5y)1.46%
ROIC(3y)N/A
ROIC(5y)N/A
EKI.PA Yearly ROA, ROE, ROICEKI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10 -15

1.3 Margins

  • EKI's Gross Margin of 57.30% is fine compared to the rest of the industry. EKI outperforms 65.63% of its industry peers.
  • EKI's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EKI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.64%
GM growth 5Y0.79%
EKI.PA Yearly Profit, Operating, Gross MarginsEKI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EKI.PA Health Analysis

2.1 Basic Checks

  • EKI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EKI has about the same amout of shares outstanding than it did 1 year ago.
  • EKI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EKI has a worse debt to assets ratio.
EKI.PA Yearly Shares OutstandingEKI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
EKI.PA Yearly Total Debt VS Total AssetsEKI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.02, we must say that EKI is in the distress zone and has some risk of bankruptcy.
  • EKI has a Altman-Z score of 1.02. This is in the lower half of the industry: EKI underperforms 62.50% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that EKI is not too dependend on debt financing.
  • EKI has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACCN/A
WACC7.71%
EKI.PA Yearly LT Debt VS Equity VS FCFEKI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • EKI has a Current Ratio of 1.82. This is a normal value and indicates that EKI is financially healthy and should not expect problems in meeting its short term obligations.
  • EKI's Current ratio of 1.82 is in line compared to the rest of the industry. EKI outperforms 53.13% of its industry peers.
  • A Quick Ratio of 1.39 indicates that EKI should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.39, EKI perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.39
EKI.PA Yearly Current Assets VS Current LiabilitesEKI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EKI.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.05% over the past year.
  • Looking at the last year, EKI shows a very negative growth in Revenue. The Revenue has decreased by -10.73% in the last year.
  • Measured over the past years, EKI shows a small growth in Revenue. The Revenue has been growing by 2.51% on average per year.
EPS 1Y (TTM)19.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.5%
Revenue 1Y (TTM)-10.73%
Revenue growth 3Y-6.28%
Revenue growth 5Y2.51%
Sales Q2Q%-20.49%

3.2 Future

  • EKI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.96% yearly.
  • EKI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.53% yearly.
EPS Next Y-126.67%
EPS Next 2Y-42.26%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue Next Year6.3%
Revenue Next 2Y8.51%
Revenue Next 3Y8.49%
Revenue Next 5Y13.53%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EKI.PA Yearly Revenue VS EstimatesEKI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
EKI.PA Yearly EPS VS EstimatesEKI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. EKI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EKI. In the last year negative earnings were reported.
  • Also next year EKI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKI.PA Price Earnings VS Forward Price EarningsEKI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • 81.25% of the companies in the same industry are more expensive than EKI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.11
EKI.PA Per share dataEKI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EKI's earnings are expected to grow with 16.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.26%
EPS Next 3Y16.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EKI.PA Dividend Analysis

5.1 Amount

  • EKI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EKI.PA Fundamentals: All Metrics, Ratios and Statistics

EKINOPS

EPA:EKI (4/27/2026, 7:00:00 PM)

2.66

+0.31 (+12.95%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)03-10
Earnings (Next)N/A
Inst Owners42.19%
Inst Owner ChangeN/A
Ins Owners13.65%
Ins Owner ChangeN/A
Market Cap71.90M
Revenue(TTM)105.04M
Net Income(TTM)-5.63M
Analysts75.56
Price Target3.06 (15.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.79%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-118.75%
EPS NY rev (3m)-118.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.61%
Revenue NY rev (3m)-6.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF 20.65
P/B 0.68
P/tB 1.77
EV/EBITDA 9.11
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)0.13
OCFY4.84%
SpS3.89
BVpS3.92
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.9%
ROE -5.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.3%
FCFM N/A
ROA(3y)-1.59%
ROA(5y)0.97%
ROE(3y)-2.83%
ROE(5y)1.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.64%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA 4.23
Cap/Depr 195.49%
Cap/Sales 19.4%
Interest Coverage N/A
Cash Conversion 48.37%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.39
Altman-Z 1.02
F-Score5
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)108.65%
Cap/Depr(5y)87.1%
Cap/Sales(3y)11.38%
Cap/Sales(5y)8.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.5%
EPS Next Y-126.67%
EPS Next 2Y-42.26%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.73%
Revenue growth 3Y-6.28%
Revenue growth 5Y2.51%
Sales Q2Q%-20.49%
Revenue Next Year6.3%
Revenue Next 2Y8.51%
Revenue Next 3Y8.49%
Revenue Next 5Y13.53%
EBIT growth 1Y35.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year198.11%
EBIT Next 3Y74.32%
EBIT Next 5YN/A
FCF growth 1Y-255.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.25%
OCF growth 3Y-28.17%
OCF growth 5Y-13.61%

EKINOPS / EKI.PA Fundamental Analysis FAQ

What is the fundamental rating for EKI stock?

ChartMill assigns a fundamental rating of 2 / 10 to EKI.PA.


Can you provide the valuation status for EKINOPS?

ChartMill assigns a valuation rating of 1 / 10 to EKINOPS (EKI.PA). This can be considered as Overvalued.


Can you provide the profitability details for EKINOPS?

EKINOPS (EKI.PA) has a profitability rating of 3 / 10.


What is the earnings growth outlook for EKINOPS?

The Earnings per Share (EPS) of EKINOPS (EKI.PA) is expected to decline by -126.67% in the next year.